Annovis Bio Inc

ANVSNYSE · USD
1.04USD0.00 (-7.15%)
162

Annovis Bio Inc (ANVS) Option Chain

As of September 15, 2026, Annovis Bio Inc is trading at $1.04, a -7.15% change from the previous close. The nearest expiration is Sep 18, 2026. Implied volatility is 371.7%. IV Rank is 42%.

Read more

Tracking the ANVS option chain helps you see every strike and expiry on Annovis Bio Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Annovis Bio Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ANVS options activity at a glance. Use our scanner to monitor the ANVS option chain in real time and filter for the ANVS options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ANVS stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ANVS option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ANVS stock options are being actively traded and where they are not.

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the traumatic brain injury and stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia.

The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Annovis Bio Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ANVS options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ANVS stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile46.03% Neutral
  • Market cap (M$)44
  • 52 weeks high-81.09%
  • 52 weeks low-5.45%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$10.50
    909.62% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-11
  • P/E
  • Future P/E
  • EPS (ttm)-1.79
  • EPS growth next 5 years-2.67%

As of September 15, 2026

2026-09-18
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.022285220.180.540.550.900.50-55.360.050.000.0522799.98
33.9446000.460.040.501.00-10.710.150.000.15010166.06
92.6717500.050.000.051.50+33.932.000.461.54017.33
99.728200.550.000.552.00+78.570.351.400.96-0.08050.28
99.99500.050.000.052.50+123.211.101.651.46-0.08040.01

As of September 15, 2026

Scan the full option chain in one place

Browse the full ANVS option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial